BioSpace News Archive

Deals

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Sept. 19, 2019

Kala Pharmaceuticals, Inc., announced that the Company granted a non-statutory stock option to one new employee as an inducement award outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.

September 19, 2019
·
1 min read
Business

Zimmer Biomet Announces Multinational Distribution Agreement with Align Technology for iTero Element® Intraoral Scanners

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a multinational distribution agreement with Align Technology, Inc. (NASDAQ: ALGN), for the award-winning iTero Element family of intraoral scanners.

September 19, 2019
·
4 min read
BioMidwest

Vireo Health Announces DTC Eligibility for Publicly Traded Shares

Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, today announced that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States.

September 19, 2019
·
1 min read
Business

Tampa General Hospital Receives Prestigious Magnet Designation for Fourth Consecutive Time

Tampa General Hospital learned it has attained Magnet recognition, the highest national honor in professional nursing practice, for the fourth consecutive time.

September 19, 2019
·
5 min read
Genetown

CVS Health Offering Nearly 600 Free Wellness Screening Events in 12 Markets Across U.S

Annual Project Health events at CVS Pharmacy locations have delivered more than $127 million worth of free health services since 2006

September 19, 2019
·
4 min read
Policy

FARMACEUTICALRX LLC of Pennsylvania Announces That it Received Full Certification to Operate its Pennsylvania Medical Marijuana Grower/Processor Operations

The Company commenced harvesting in August and projects that it will commence medical product sales in Pennsylvania in the coming weeks.

September 19, 2019
·
2 min read
Business

Celsius Therapeutics Signs Multiple Agreements with Academic Institutions to Access Samples for the Identification of Novel Targets in Immune Checkpoint Therapy Resistance

Celsius Applying its Single-Cell Genomics Platform Across Multiple Tumor Types and Immuno-Oncology Clinical Trials

September 19, 2019
·
2 min read
Lone Star Bio

C-Hear Invited to Prestigious Big Design Conference

C-Hear founder and CEO Adena Harmon will speak at this year’s event, to be held Sept. 20-21 at Gilley’s in Dallas.

September 19, 2019
·
2 min read
Lone Star Bio

Soliton Begins Treatments In Proof-Of-Concept Trial For Keloid Scars

Patient treatments have begun in the Company’s proof-of-concept clinical trial for the treatment of keloid and hypertrophic scars at Clear Dermatology & Aesthetic Center in Scottsdale, AZ, by Dr. Brenda LaTowsky, Board Certified Dermatologist.

September 19, 2019
·
5 min read
Business

Manufacturing and Corporate Development

Appointment of Chief Business Officer and Chief Manufacturing Officer will accelerate company’s evolution into an integrated therapeutics company

September 19, 2019
·
3 min read